Understanding how skin injuries from chemical agents affect cell behavior
Coordinated cytoskeletal and cell adhesion dynamics in vesicant induced skin injury
This study is looking at how certain chemicals that cause skin blisters affect the way skin cells stick together and stay strong, with the hope of finding better ways to treat and prevent serious skin injuries from chemical exposure.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11044283 on NIH RePORTER |
What this research studies
This research investigates the effects of chemical agents that cause skin blistering, focusing on how these agents disrupt cell adhesion and the cytoskeleton in skin cells. By studying the dynamics of cell adhesion and cytoskeletal remodeling, the research aims to uncover the mechanisms behind skin injuries caused by chemical warfare. The approach involves using advanced biological models to observe how specific proteins, like ACF7, influence cell behavior during injury. The ultimate goal is to develop effective medical countermeasures to treat and prevent severe skin damage.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced skin injuries due to chemical exposure or those at risk of such exposure.
Not a fit: Patients with skin injuries from non-chemical sources may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that minimize skin damage and improve recovery for individuals exposed to chemical agents.
How similar studies have performed: Previous research has shown promise in understanding cell adhesion dynamics, but this specific approach to vesicant-induced skin injury is relatively novel.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Wu, Xiaoyang — University of Chicago
- Study coordinator: Wu, Xiaoyang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.